BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moudjou M, Castille J, Passet B, Herzog L, Reine F, Vilotte JL, Rezaei H, Béringue V, Igel-Egalon A. Improving the Predictive Value of Prion Inactivation Validation Methods to Minimize the Risks of Iatrogenic Transmission With Medical Instruments. Front Bioeng Biotechnol 2020;8:591024. [PMID: 33335894 DOI: 10.3389/fbioe.2020.591024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Knight R. Overview on Treatment of Prion Diseases and Decontamination of Prions. Prions and Diseases 2023. [DOI: 10.1007/978-3-031-20565-1_35] [Reference Citation Analysis]
2 Igel A, Fornara B, Rezaei H, Béringue V. Prion assemblies: structural heterogeneity, mechanisms of formation, and role in species barrier. Cell Tissue Res 2022. [DOI: 10.1007/s00441-022-03700-2] [Reference Citation Analysis]
3 Martin D, Reine F, Herzog L, Igel-Egalon A, Aron N, Michel C, Moudjou M, Fichet G, Quadrio I, Perret-Liaudet A, Andréoletti O, Rezaei H, Béringue V. Prion potentiation after life-long dormancy in mice devoid of PrP. Brain Commun 2021;3:fcab092. [PMID: 33997785 DOI: 10.1093/braincomms/fcab092] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]